Skip to Main Content
Beta test
our new site.
(
NLM Technical Bulletin
)
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
An Epidemiological Study to Describe Symptom Control and Impact of Gastroesophageal Reflux Disease
This study has been completed.
Study NCT01134367 Information provided by AstraZeneca
First Received on May 28, 2010. Last Updated on July 13, 2011
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
GERD
Additional conditions recognized in this trial
Gastroesophageal Reflux
More general conditions related to this trial
Deglutition Disorders
Digestive System Diseases
Esophageal Diseases
Esophageal Motility Disorders
Gastrointestinal Diseases
Sponsors listed in this trial
AstraZeneca
Back to top of Main Content